Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Balance, at start of period (in shares) at Jan. 29, 2022   3,354,000        
Balance, at start of period at Jan. 29, 2022 $ 1,308 $ 47 $ 220,967 $ 77,093 $ 0 $ (296,799)
Balance, at start of period, treasury stock (in shares) at Jan. 29, 2022           1,328,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (11,914)     (11,914)    
Exercise of stock options and vesting of restricted stock units (in shares)   76,000       (76,000)
Exercise of stock options and vesting of restricted stock units 0   (5,038) (11,935)   $ 16,973
Share-based compensation 2,393   2,393      
Repurchase of common stock (in shares)   (29,000)       29,000
Repurchase of common stock (1,890)         $ (1,890)
Balance, at end of period (in shares) at Apr. 30, 2022   3,401,000        
Balance, at end of period at Apr. 30, 2022 (10,103) $ 47 218,322 53,244 0 $ (281,716)
Balance, at end of period, treasury stock (in shares) at Apr. 30, 2022           1,281,000
Balance, at start of period (in shares) at Jan. 29, 2022   3,354,000        
Balance, at start of period at Jan. 29, 2022 1,308 $ 47 220,967 77,093 0 $ (296,799)
Balance, at start of period, treasury stock (in shares) at Jan. 29, 2022           1,328,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (39,326)          
Repurchase of common stock (in shares) 0          
Balance, at end of period (in shares) at Oct. 29, 2022   3,415,000        
Balance, at end of period at Oct. 29, 2022 $ (32,401) $ 47 222,787 22,872 0 $ (278,107)
Balance, at end of period, treasury stock (in shares) at Oct. 29, 2022           1,267,000
Balance, at start of period (in shares) at Apr. 30, 2022   3,401,000        
Balance, at start of period at Apr. 30, 2022 (10,103) $ 47 218,322 53,244 0 $ (281,716)
Balance, at start of period, treasury stock (in shares) at Apr. 30, 2022           1,281,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 7,036     7,036    
Exercise of stock options and vesting of restricted stock units (in shares)   12,000       (12,000)
Exercise of stock options and vesting of restricted stock units 0   (636) (2,035)   $ 2,671
Share-based compensation 2,620   2,620      
Repurchase of common stock (in shares)   (1,000)       1,000
Repurchase of common stock (66)         $ (66)
Balance, at end of period (in shares) at Jul. 30, 2022   3,412,000        
Balance, at end of period at Jul. 30, 2022 (513) $ 47 220,306 58,245 0 $ (279,111)
Balance, at end of period, treasury stock (in shares) at Jul. 30, 2022           1,270,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (34,448)     (34,448)    
Exercise of stock options and vesting of restricted stock units (in shares)   5,000       (5,000)
Exercise of stock options and vesting of restricted stock units 0   (123) (925)   $ 1,048
Share-based compensation $ 2,604   2,604      
Repurchase of common stock (in shares) 0 (2,000)       2,000
Repurchase of common stock $ (44)         $ (44)
Balance, at end of period (in shares) at Oct. 29, 2022   3,415,000        
Balance, at end of period at Oct. 29, 2022 $ (32,401) $ 47 222,787 22,872 0 $ (278,107)
Balance, at end of period, treasury stock (in shares) at Oct. 29, 2022           1,267,000
Balance, at start of period (in shares) at Jan. 28, 2023 3,688,000 3,688,000        
Balance, at start of period at Jan. 28, 2023 $ 307,569 $ 50 229,573 355,736 0 $ (277,790)
Balance, at start of period, treasury stock (in shares) at Jan. 28, 2023 1,265,000         1,265,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (73,427)     (73,427)    
Exercise of stock options and vesting of restricted stock units (in shares)   62,000       (62,000)
Exercise of stock options and vesting of restricted stock units 0   (1,036) (12,497)   $ 13,533
Share-based compensation 1,871   1,871      
Repurchase of common stock (in shares)   (21,000)       21,000
Repurchase of common stock (354)         $ (354)
Balance, at end of period (in shares) at Apr. 29, 2023   3,729,000        
Balance, at end of period at Apr. 29, 2023 $ 235,659 $ 50 230,408 269,812 0 $ (264,611)
Balance, at end of period, treasury stock (in shares) at Apr. 29, 2023           1,224,000
Balance, at start of period (in shares) at Jan. 28, 2023 3,688,000 3,688,000        
Balance, at start of period at Jan. 28, 2023 $ 307,569 $ 50 229,573 355,736 0 $ (277,790)
Balance, at start of period, treasury stock (in shares) at Jan. 28, 2023 1,265,000         1,265,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (154,294)          
Repurchase of common stock (in shares) 0          
Balance, at end of period (in shares) at Oct. 28, 2023 3,746,000 3,746,000        
Balance, at end of period at Oct. 28, 2023 $ 147,955 $ 50 223,343 185,120 0 $ (260,558)
Balance, at end of period, treasury stock (in shares) at Oct. 28, 2023 1,207,000         1,207,000
Balance, at start of period (in shares) at Apr. 29, 2023   3,729,000        
Balance, at start of period at Apr. 29, 2023 $ 235,659 $ 50 230,408 269,812 0 $ (264,611)
Balance, at start of period, treasury stock (in shares) at Apr. 29, 2023           1,224,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (44,056)     (44,056)    
Exercise of stock options and vesting of restricted stock units (in shares)   16,000       (16,000)
Exercise of stock options and vesting of restricted stock units 0   (214) (3,321)   $ 3,535
Share-based compensation (5,681)   (5,681)      
Repurchase of common stock (6)         (6)
Balance, at end of period (in shares) at Jul. 29, 2023   3,745,000        
Balance, at end of period at Jul. 29, 2023 185,916 $ 50 224,513 222,435 0 $ (261,082)
Balance, at end of period, treasury stock (in shares) at Jul. 29, 2023           1,208,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (36,811)     (36,811)    
Exercise of stock options and vesting of restricted stock units (in shares)   2,000       (2,000)
Exercise of stock options and vesting of restricted stock units 0   (29) (504)   $ 533
Share-based compensation $ (1,141)   (1,141)      
Repurchase of common stock (in shares) 0 (1,000)       1,000
Repurchase of common stock $ (9)         $ (9)
Balance, at end of period (in shares) at Oct. 28, 2023 3,746,000 3,746,000        
Balance, at end of period at Oct. 28, 2023 $ 147,955 $ 50 $ 223,343 $ 185,120 $ 0 $ (260,558)
Balance, at end of period, treasury stock (in shares) at Oct. 28, 2023 1,207,000         1,207,000